Plasmapheresis in systemic lupus erythematosus: a cautionary note

Area of Science:

• Immunology
• Rheumatology
• Nephrology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune complex deposition.
• Plasmapheresis is a therapeutic apheresis technique that removes plasma and its components.

Observation:

• Four SLE patients were treated solely with plasmapheresis.
• Clinical and laboratory parameters were monitored during and after treatment.

Findings:

• No consistent correlation was found between circulating immune complexes and treatment response.
• Lymphocytotoxic antibodies decreased in 75% of patients, but T lymphocytes, complement, and immunoglobulin levels showed no significant changes.
• All patients experienced clinical and laboratory deterioration within six months, leading to protocol discontinuation.

Implications:

• Plasmapheresis as a standalone therapy may be ineffective and potentially harmful for SLE patients.
• Concomitant immunosuppressive therapies are crucial for managing SLE effectively.
• Further research is needed to determine the optimal role of plasmapheresis in SLE management, possibly in combination with other treatments.